Meta-Analysis of Association Between C-Reactive Protein and Immediate Success of Electrical Cardioversion in Persistent Atrial Fibrillation

American Journal of Cardiology

Volumn 101, Issue 12, 2008, Pages 1749-1752

  Liu, Tong ^a   Li, Lijian ^b   Korantzopoulos, Panagiotis ^c   Goudevenos, John A ^c   Li, Guangping ^a  

^a Second Hospital   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CARDIOVERSION; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; INFORMATION RETRIEVAL; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; ELECTRIC COUNTERSHOCK; HUMANS; PROGNOSIS; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 44749094353     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.02.066     Document Type: Article

References (26)

1. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
2. Issac T.T., Dokainish H., and Lakkis N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 50 (2007) 2021-2028
3. Watson T., Kakar P., and Lip G.Y. Cardioversion for atrial fibrillation: does inflammation matter?. Am J Cardiol 99 (2007) 1617-1618
4. Liu T., Li G., Li L., and Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49 (2007) 1642-1648
5. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., and Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000) 2008-2012
6. Downs S.H., and Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52 (1998) 377-384
7. Hozo S.P., Djulbegovic B., and Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5 (2005) 13
8. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
9. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol 94 (2004) 508-510
10. Korantzopoulos P., Kolettis T.M., Kountouris E., Siogas K., and Goudevenos J.A. Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates?. Int J Clin Pract 59 (2005) 881-885
11. Zarauza J., Rodriguez Lera M.J., Farinas Alvarez C., Hernando J.P., Ceballos B., Gutierrez B., Perez J., and Cuesta J.M. Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion. Rev Esp Cardiol 59 (2006) 125-129
12. Watanabe E., Arakawa T., Uchiyama T., Kodama I., and Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 108 (2006) 346-353
13. Cosgrave J., Foley J.B., Bahadur K., Bennett K., Crean P., and Walsh M.J. Inflammatory markers are not associated with outcomes following elective external cardioversion. Int J Cardiol 110 (2006) 373-377
14. Gomez Martinez E., Borras Palle S., Valls Grima F., Miralles Serrano L.L., Molto Guillamont L., Jarabo Bueno M.M., Gomez Casals V., and Valentin Segura V. Inflammatory state in patients with atrial fibrillation before and after electrical cardioversion. Med Intensiva 31 (2007) 126-132
15. Cosio F.G., Aliot E., Botto G.L., Heidbüchel H., Geller C.J., Kirchhof P., De Haro J.C., Frank R., Villacastin P.J., Vijgen J., and Crijns H. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. Europace 10 (2008) 21-27
16. Murray K.T., Mace L.C., and Yang Z. Nonantiarrhythmic drug therapy for atrial fibrillation. Heart Rhythm 4 3 Suppl (2007) S88-S90
17. Ferlinz J. Our unadorned atrial fibrillation: the challenge of new enigmas. Am J Cardiol 99 (2007) 1330-1333
18. Shiroshita-Takeshita A., Brundel B.J., and Nattel S. Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 13 (2005) 181-193
19. Korantzopoulos P., Kolettis T.M., Kountouris E., Dimitroula V., Karanikis P., Pappa E., Siogas K., and Goudevenos J.A. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102 (2005) 321-326
20. Korantzopoulos P., Kolettis T.M., Galaris D., and Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007) 135-143
21. Lally J.A., Gnall E.M., Seltzer J., and Kowey P.R. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation. J Cardiovasc Electrophysiol 18 (2007) 1222-1228
22. Liu T., Li L., Korantzopoulos P., Liu E., and Li G. Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol (2007) Nov 19; [Epub ahead of print]
23. Loricchio M.L., Cianfrocca C., Pasceri V., Bianconi L., Auriti A., Calo L., Lamberti F., Castro A., Pandozi C., Palamara A., and Santini M. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 99 (2007) 1421-1424
24. Gall N.P., and Murgatroyd F.D. Electrical cardioversion for AF: the state of the art. Pacing Clin Electrophysiol 30 (2007) 554-567
25. Van Gelder I.C., Tuinenburg A.E., Schoonderwoerd B.S., Tieleman R.G., and Crijns H.J. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 84 9A (1999) 147R-151R
26. Korantzopoulos P., Kolettis T.M., Goudevenos J.A., and Siogas K. Errors and pitfalls in the non-invasive management of atrial fibrillation. Int J Cardiol 104 (2005) 125-130